Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,120 public trials 3,997 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

NCT03829540

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Albert Einstein Health Network New York, United States
View Trial Details
Recruiting

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

NCT06975865

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham- Site Number : 8400003 Birmingham, Alabama, United States
  • Phoenix Children's Hospital- Site Number : 8400028 Phoenix, Arizona, United States
  • University of California San Francisco- Site Number : 8400040 Fresno, California, United States
  • Oncology & Hematology Associates of West Broward- Site Number : 8400029 Coral Springs, Florida, United States
View all 53 locations
View Trial Details
Recruiting

Luspatercept for CIA in AML

NCT07663864

Conditions
Anemia, Chemotherapy-inducing Anemia, Hematologic Diseases, +6 more
Locations
  • Department of Hematology, Guangdong Second Provincial General Hospital Guangzhou, Guangdong, China
View Trial Details
Recruiting

Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients

NCT07663253

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Shenzhen People's Hospital Shenzhen, Guangdong, China
  • The First Affiliated Hospital of Guangxi Medical University Naning, Guangxi, China
View all 13 locations
View Trial Details
Recruiting

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

NCT05401097

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • UNC Hospitals, University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • UT Southwestern Medical Center at Dallas Dallas, Texas, United States
View Trial Details
Recruiting

A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

NCT06887803

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Azienda Ospedaliero Universitaria Careggi Firenze, Struttura Complessa di Ematologia Florence, Italy
  • IRCCS Clinical Institute Humanitas Rozzano, Milan, Italy
  • Istituto di Ematolgia e Oncologia Medica Bologna, Italy
  • Istituto Romagnolo per lo Studio dei Tumori Meldola, Italy
View Trial Details

Related conditions